Anti-Counterfeiting in Pharmaceutical Industry - Veritech

All Blogs

Anti-Counterfeiting Measures in the Pharmaceutical Industry

Veritech Anti-Counterfeiting Measures in the Pharmaceutical Industry

May 6

Anti-Counterfeiting Measures in the Pharmaceutical Industry

What is Anti-Counterfeiting?

Anti-counterfeiting refers to the methods and tactics used to stop manufacturing, selling, and distributing imitation goods. Counterfeiting is the process of making and distributing faulty goods that are styled to resemble authentic, original goods. Numerous items, such as apparel, accessories, electronics, and pharmaceuticals, can be counterfeit products. Anti-counterfeiting methods safeguard consumers from the potential harm of using fake goods and the rights and income of real intellectual property owners. Holograms, security inks, and RFID tags are a few technological solutions that can be used with legal and regulatory safeguards like trademark and patent protection, customs enforcement, and criminal prosecution of counterfeiters.

Need for anti-counterfeit technologies-

The pharmaceutical sector faces a big problem with counterfeiting because it threatens the profits of legal manufacturers and the patient’s health and safety. As a result, the industry has been actively inventing and implementing numerous anti-counterfeiting solutions to fight this problem.
Some of the upcoming anti-counterfeiting measures the pharmaceutical sector is likely to use include the following:

  1. Utilising blockchain technology: By offering an unchangeable and transparent record of every transaction in the supply chain, blockchain technology has the potential to transform the pharmaceutical sector completely. This technology makes it more challenging for counterfeiters to insert fake drugs into the supply chain by tracking the transit of medications from the manufacturer to the patient.
  2. Authentication technologies: Holograms, color-shifting inks, and RFID tags are just a few of the authentication technologies that can be employed to confirm the legitimacy of medications. As these technologies advance and become more affordable, smaller producers will have easier access.
  3. Serialisation: Serialisation utilizes a serial number or barcode to identify individual medicine packages in a specific way. The supply chain may be tracked and authenticated using this technology, making it more challenging for counterfeiters to make fake pharmaceuticals.
  4. Mobile applications: By scanning a QR code or barcode on the package, mobile applications can be used to check the legitimacy of medications. These apps can also offer details about the drug, such as dosage recommendations and any side effects.

To tackle the issue of counterfeit medications, the pharmaceutical industry is expected to implement a combination of these anti-counterfeiting techniques in the future. These restrictions will safeguard patient safety and well-being and the earnings of legal manufacturers.

Counterfeit pharmaceuticals seriously threaten the public’s health and safety globally. Up to 10% of medicines in low- and middle-income countries are considered fake or subpar, according to the World Health Organisation (WHO), resulting in an estimated 100,000 fatalities annually. However, counterfeit drugs are a significant issue in developing nations but also a major problem in the United States. Therefore, anti-counterfeiting procedures must be created and implemented to protect patient safety and preserve the integrity of the supply chain as the pharmaceutical business expands and changes

Anti-counterfeiting measures have existed for many years, with some of the earliest examples including holograms and watermarks on the packaging. However, these measures have proven insufficient as counterfeiters have become increasingly sophisticated. In response, the pharmaceutical industry has begun to adopt new technologies and strategies to combat counterfeiting.

Another tactic is utilizing authentication technologies, such as color-changing inks and other challenging-to-replicate security features. These characteristics may discourage counterfeiters from producing accurate imitations of medicinal items. However, it’s crucial to remember that using authentication alone won’t be enough to stop counterfeiting; additional actions must be taken.
Although these methods and technologies show great promise for the future of anti-counterfeiting measures in the pharmaceutical sector, issues still need to be resolved. The expense of putting these protections into place is one of these obstacles. In addition, using serialization, RFID tagging, and other technology can be pricey, especially for smaller businesses with different financial means than more prominent pharmaceutical organizations.

The need for international cooperation in the fight against counterfeiting is another obstacle. Since counterfeiters cross borders, it is challenging to find and prosecute them. To effectively combat counterfeiting, nations must collaborate and exchange resources and information.
When putting new anti-counterfeiting measures into place, privacy issues must also be taken into consideration. For example, RFID tags and other supply chain tracking technologies can gather private information about individuals and their medical history. Therefore, the patient’s privacy rights and the secure collection and storage of this data must be maintained.

Future for Anti-Counterfeiting Packaging

Though current efforts to combat fake medications through inventive packaging methods are still in their infancy, prospects appear bright. While counterfeit pharmaceuticals are still getting worse, technological advancements are making it harder for counterfeiters. Nano-optics technology remains a significant, largely untapped technology that can be bought into the play.

Implementing anti-counterfeiting procedures might be difficult.

Some issues need to be resolved even though these techniques and techniques show considerable promise for the future of anti-counterfeiting measures in the pharmaceutical business. The expense of putting these safeguards into effect is one such difficulty. In addition, for smaller companies with different resources, than more prominent pharmaceutical corporations, RFID tagging, serialization, and other technologies might be expensive. This might make it difficult for some businesses to enter the market and prevent the general use of these technologies.

The need for international cooperation in the fight against counterfeiting is another obstacle. Since counterfeiters cross borders, it is challenging to find and prosecute them. To effectively combat counterfeiting, nations must collaborate and exchange resources and information.
When putting new anti-counterfeiting measures into place, privacy issues must also be taken into consideration. For example, RFID tags and other supply chain tracking technologies can gather private information about individuals and their medical history.

The patient’s privacy rights and the secure collection and storage of this data must be maintained. Nevertheless, the future of anti-counterfeiting solutions in the pharmaceutical business is bright despite these obstacles. As technology develops further, new ways to stop counterfeiting will become available.